Notification, 15 June 1988.
The effect of this Notification is to prohibit the manufacture and sale of the following in India: fixed-dose combinations of estrogen and progestin (other than oral contraceptives) having, per tablet, an estrogen content of more than 50 mcg (equivalent to ethinyl estradiol) and a progestin content of more than 3 mg (equivalent to norethisterone acetate).